Printer Friendly

Browse Biotechnology industry topic

Licensing agreements subtopic

Articles

1-300 out of 377 article(s) nextnext page
Title Author Type Date Words
United States : Seattle Genetics and BeiGene Announce Global License Agreement for Advanced Preclinical Product Candidate. Nov 9, 2019 359
Yield10 Bioscience signs research agreement with J. R. Simplot Company. Oct 23, 2019 134
United States : Editas Medicine and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Cell Medicines. Oct 14, 2019 302
Abuse Deterrent Formulation Technologies Market, 2019-2030: Current Market Landscape and Future Potential of Industry Players. Oct 7, 2019 868
Cantargia extends licensing agreement with BioWa extend around the POTELLIGENT Technology. Aug 26, 2019 305
Cantargia extends licensing agreement with BioWa extend around the POTELLIGENT Technology. Aug 26, 2019 301
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China. Aug 21, 2019 185
Alligator Bioscience announces signing of license agreement with Biotheus Inc for Greater China. Aug 21, 2019 205
Alligator Bioscience announces signing of license agreement with Biotheus Inc for Greater China. Aug 21, 2019 206
Alligator Bioscience announces antibody agreement with Biotheus Inc for Greater China. Aug 21, 2019 181
Exelixis signs exclusive collaboration, option and license agreement with Aurigene Discovery Technologies. Aug 2, 2019 292
Exelixis signs exclusive collaboration, option and license agreement with Aurigene Discovery Technologies. Aug 2, 2019 288
Exelixis and Aurigene partner to advance novel therapies for cancer. Aug 1, 2019 241
Exelixis and Aurigene partner to advance novel therapies for cancer. Aug 1, 2019 237
Acerus and Aytu Bioscience to Co-promote Natesto in the United States. Jul 31, 2019 862
Lexaria Bioscience trumpets its slate of DehydraTECH licensing agreements. Jul 30, 2019 367
Sirion Biotech Licenses Technology to National Institute of Allergy and Infectious Diseases to Boost Clinical Efficacy of Lentivector Gene Therapy for X-Linked SCID. Jun 13, 2019 528
Sinovant Sciences' Derazantinib's Clinical Trial Application Approved by the China National Medical Products Administration. May 2, 2019 458
Puma Biotechnology signs license agreement with Pierre Fabre. Apr 3, 2019 212
Puma Biotechnology signs license agreement with Pierre Fabre. Apr 3, 2019 208
China National Biotec Group, ImmunoBiology Enter Licensing Agreement to Co-Develop Next Generation Vaccine against Pneumococcal Disease in Greater China. Mar 19, 2019 524
Promega Enters License Agreement with Broad Institute to Access CRISPR-Cas9 Gene Editing Technology. Jan 30, 2019 279
United Therapeutics concludes ralinepag license agreement with Arena Pharmaceuticals. Jan 25, 2019 183
United Therapeutics concludes ralinepag license agreement with Arena Pharmaceuticals. Jan 25, 2019 179
China's Bio-Thera Solutions Partners with Cipla to Market Key Cancer Biosimilar. Jan 14, 2019 377
Dare Bioscience announces licensing agreement with Hammock, TriLogic. Dec 6, 2018 160
Alligator Bioscience announces receipt of over USD3.5m in payments under partnership agreement with AbClon. Nov 8, 2018 305
Alligator Bioscience announces receipt of over USD3.5m in payments under partnership agreement with AbClon. Nov 8, 2018 301
OSE Immunotherapeutics Regains Worldwide Rights to its CD28 antagonist FR104 from Janssen Biotech. Nov 2, 2018 448
Rigel Pharmaceuticals Inc signs exclusive license and supply agreement with Kissei Pharmaceutical Co Ltd. Oct 30, 2018 212
Rigel Pharmaceuticals Inc signs exclusive license and supply agreement with Kissei Pharmaceutical Co Ltd. Oct 30, 2018 216
Arcis Biotechnology signs license agreement with Teleflex. Oct 16, 2018 196
Arcis Biotechnology signs license agreement with Teleflex. Oct 16, 2018 192
Themis Bioscience signs exclusive licensing agreement with Max-Planck-Innovation for oncolytic virotherapies. Oct 11, 2018 291
Themis Bioscience signs exclusive licensing agreement with Max-Planck-Innovation for oncolytic virotherapies. Oct 11, 2018 287
Themis Bioscience Inks Exclusive Licensing Agreement with Max-Planck-Innovation to Develop and Commercialise Oncolytic Virotherapies. Oct 11, 2018 361
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement. Oct 10, 2018 401
Vitrolife signs license and commercialisation agreement with Illumina Inc on preimplantation genetic testing for IVF. Oct 3, 2018 277
Vitrolife signs license and commercialisation agreement with Illumina Inc on preimplantation genetic testing for IVF. Oct 3, 2018 273
GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment. Oct 3, 2018 208
Yield10 Bioscience grants research license to Forage Genetics for sorghum. Sep 21, 2018 279
Active Biotech announces regain of global rights to development and commercialisation of laquinimod from Teva. Sep 6, 2018 252
Active Biotech announces regain of global rights to development and commercialisation of laquinimod from Teva. Sep 6, 2018 253
Acadia Pharmaceuticals, Neuren Pharmaceuticals Ink License Agreement for the North American Development and Commercialization of Trofinetide in Rett Syndrome. Aug 10, 2018 705
Acadia Pharmaceuticals signs North American license agreement with Neuren Pharmaceuticals. Clinical report Aug 8, 2018 252
Acadia Pharmaceuticals signs North American license agreement with Neuren Pharmaceuticals. Clinical report Aug 8, 2018 248
Yield10 Bioscience signs research license agreement covering CRISPR-Cas9. Aug 8, 2018 185
Acadia announces exclusive license agreement with Neuran on Trofinetide. Aug 6, 2018 343
Novartis commits to immuno-dermatology with new license agreement. Jul 19, 2018 199
Novartis commits to immuno-dermatology with new license agreement. Jul 19, 2018 195
Compugen reports FDA clearance of Bayer's IND application for BAY 1905254. Jul 2, 2018 203
Oxford BioMedica and Axovant Sciences enter licence agreement for Parkinson's disease treatment. Jun 6, 2018 201
Oxford BioMedica and Axovant Sciences enter licence agreement for Parkinson's disease treatment. Jun 6, 2018 197
Kineta, Roche enter exclusive chronic pain development pact. May 1, 2018 290
Juniper Pharmaceuticals licenses intravaginal ring platform to Dare Bioscience. Apr 25, 2018 163
Dare Bioscience, Juniper emter into exclusive worldwide license agreement. Apr 25, 2018 193
ArQule Licenses Basilea to Develop and Commercialise for Derazantinib. Apr 19, 2018 430
Basilea signs licence agreement with ArQule for derazantinib. Apr 17, 2018 223
Basilea signs licence agreement with ArQule for derazantinib. Apr 17, 2018 219
ArQule, Basilea Pharmaceutica enter exclusive license agreement for derazantinib. Apr 17, 2018 194
Morphotek Licenses Proprietary Eribulin-Linker Payload to Bliss Biopharmaceutical for Development of Therapeutic ADC. Apr 16, 2018 290
Morphotek Licenses Proprietary Eribulin-Linker Payload to Bliss Biopharmaceutical for Development of Therapeutic ADC. Apr 12, 2018 290
Exelixis Earns USD 10m Payment Following EMA Acceptance of Ipsen Application for New Indication for Cabometyx for Previously Treated Advanced HCC. Mar 29, 2018 267
Japan : Chugai Starts Activities towards Commercialization of Foundation Medicines Products in Japan. Mar 17, 2018 411
Seattle Genetics and Pieris Pharmaceuticals Partner to Evaluate Novel Bispecific Immuno-Oncology Agents. Feb 14, 2018 357
United States : Pieris Pharmaceuticals and Seattle Genetics Announce Multi-program Immuno-oncology Collaboration. Feb 12, 2018 464
ArQule, Roivant Sciences enter into license agreement for derazantinib in China. Feb 7, 2018 176
Puma Biotechnology and CANbridge Life Sciences enter exclusive licensing agreement. Feb 2, 2018 189
Puma Biotechnology and CANbridge Life Sciences enter exclusive licensing agreement. Feb 2, 2018 185
Nektar jumps after Bloomberg report on sale exploration. Feb 2, 2018 104
Puma Biotechnology, Medison Pharma enter into licensing agreement for Nerlynx. Jan 30, 2018 121
Md. biotech firm to get at least $140M in licensing deal. Jan 8, 2018 153
United States : Janssen Enters Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy. Dec 23, 2017 409
Arvinas expands ongoing Protac license agreement with Genentech. Nov 17, 2017 156
Arvinas expands ongoing Protac license agreement with Genentech. Nov 17, 2017 152
Arvinas, Genentech Expand Ongoing License Agreement. Nov 16, 2017 216
Hydra Biosciences and Boehringer Ingelheim Collaboration Initiates Clinical Trial of TRPC4/5 Inhibitor for CNS Disorders. Nov 3, 2017 244
Ablynx and Sanofi enter strategic collaboration to develop Nanobody product candidates. Jul 20, 2017 236
Ablynx and Sanofi enter strategic collaboration to develop Nanobody product candidates. Jul 20, 2017 232
Seattle Genetics to Terminate Sacituzumab Govitecan License Agreement with Immunomedics; Will Settle Shareholder Suit. May 8, 2017 313
Collaborations extend Takeda's therapeutic reach. Feb 27, 2017 441
Momenta Pharmaceuticals passes HSR clearance for collaboration and license agreement with CSL. Feb 20, 2017 167
Momenta Pharmaceuticals passes HSR clearance for collaboration and license agreement with CSL. Feb 20, 2017 163
Seattle Genetics to License Sacituzumab Govitecan (IMMU-132) from Immunomedics. Feb 13, 2017 663
Neurocrine enters into exclusive licensing agreement with BIAL for Opicapone for treating Parkinson's disease in North America. Feb 10, 2017 268
Neurocrine enters into exclusive licensing agreement with BIAL for Opicapone for treating Parkinson's disease in North America. Feb 10, 2017 264
LIFELABS SELECTS ICP FOR MUTATION ENRICHMENT. Feb 1, 2017 610
Exelixis & Takeda partnership to commercialise and develop novel cancer therapy cabozantinib in Japan. Jan 31, 2017 313
Exelixis & Takeda partnership to commercialise and develop novel cancer therapy cabozantinib in Japan. Jan 31, 2017 309
Aduro Biotech signs exclusive license agreement with Stanford University. Jan 20, 2017 216
Aduro Biotech signs exclusive license agreement with Stanford University. Jan 20, 2017 212
Nemus Bioscience Inc partners with University of Mississippi (UM) for use of cannabinoid anti-infective platform against drug-resistant organisms. Jan 12, 2017 239
Nemus Bioscience Inc partners with University of Mississippi (UM) for use of cannabinoid anti-infective platform against drug-resistant organisms. Jan 12, 2017 235
Exelixis and Ipsen announce amendment to exclusive licensing agreement for Cabozantinib to include Canada. Dec 21, 2016 336
Exelixis and Ipsen announce amendment to exclusive licensing agreement for Cabozantinib to include Canada. Dec 21, 2016 332
Switzerland : ERS Genomics and Evolva Sign license agreement on CRISPR-Cas9 Genome Editing Patents for industrial applications. Oct 28, 2016 247
Exclusive Licensing Agreement for In-house Developed Monoclonal Antibody Farletuzumab in Latin America Concluded with Eurofarma Laboratorios S.A. Oct 4, 2016 658
United Kingdom : MedImmune out-licenses potential medicine for inflammatory diseases to Allergan. Oct 4, 2016 500
Hanmi Pharmaceutical signs development and license agreement with Genentech. Oct 3, 2016 186
Hanmi Pharmaceutical signs development and license agreement with Genentech. Oct 3, 2016 182
TaiGen Biotechnology signs Latin American licensing agreement with Productos CientA-ficos. Aug 30, 2016 170
TaiGen Biotechnology signs Latin American licensing agreement with Productos CientA-ficos. Aug 30, 2016 166
BIONOMICS RECEIVES SHARE OF FUNDS FROM LICENSE DEAL. Aug 1, 2016 500
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2016. May 9, 2016 506
United States : Sumitomo Chemical Strengthens Biorational Business -Two agreements signed with a U.S. company and an Argentina company. Apr 27, 2016 238
France,United States : CELLECTIS inks supply-license contract with RETRONECTIN. Mar 25, 2016 198
United States : Cellectis Announces RetroNectin Supply and License Agreement with Takara Bio Inc. Mar 22, 2016 211
Eisai signs exclusive license agreement with HUYA Bioscience. Feb 3, 2016 148
Eisai signs exclusive license agreement with HUYA Bioscience. Feb 3, 2016 144
Morphotek signs oncology imaging license agreement with Blaze Bioscience. Nov 11, 2015 170
Morphotek signs oncology imaging license agreement with Blaze Bioscience. Nov 11, 2015 166
Janssen Biotech signs worldwide license agreement with Alligator Bioscience. Aug 17, 2015 121
Janssen Biotech signs worldwide license agreement with Alligator Bioscience. Aug 17, 2015 117
NYU School of Medicine, Interleukin Ink Licensing Deal for Genetics-Based Osteoarthritis Test. Jul 15, 2015 492
NYU School of Medicine, Interleukin Ink Licensing Deal for Genetics-Based Osteoarthritis Test. Jul 15, 2015 461
Neurocrine Biosciences signs collaboration and licensing agreement with Mitsubishi Tanabe Pharma. Apr 3, 2015 153
Neurocrine Biosciences signs collaboration and licensing agreement with Mitsubishi Tanabe Pharma. Apr 3, 2015 149
MultiCell Immunotherapeutics signs research & development and product license agreement with Oxis Biotech. Mar 16, 2015 199
MultiCell Immunotherapeutics signs research & development and product license agreement with Oxis Biotech. Mar 16, 2015 195
Switzerland : Novartis collaborates with Intellia Therapeutics and Caribou Biosciences to explore making medicines and drug discovery tools with CRISPR genome editing technology. Jan 7, 2015 439
COMPUGEN COLLABORATES WITH BAYER HEALTHCARE. Nov 1, 2014 437
Canada : NEPTUNE TECHNOLOGIES, BLUEOCEAN sign license deal. Oct 21, 2014 228
Aduro BioTech signs second agreement with Janssen Biotech. Oct 20, 2014 162
Aduro BioTech signs second agreement with Janssen Biotech. Oct 20, 2014 158
United States : Baxter and Merrimack Pharmaceuticals Enter into Exclusive Ex-U.S. Licensing Agreement to Develop and Commercialize Novel Cancer Compound MM-398. Sep 25, 2014 310
Meridian Bioscience, UTRF ink licence deal for electrokinetic sensor technology. Aug 6, 2014 197
Sequenom executes license agreement with Mayo Medical Laboratories for undisclosed terms. Jul 30, 2014 177
Sequenom executes license agreement with Mayo Medical Laboratories for undisclosed terms. Jul 30, 2014 173
Lion Biotechnologies signs worldwide license agreement with Moffitt Cancer Centre. Jul 29, 2014 164
Lion Biotechnologies signs worldwide license agreement with Moffitt Cancer Centre. Jul 29, 2014 160
Neurotrope Bioscience signs license agreement with Icahn School of Medicine at Mount Sinai. Jul 25, 2014 167
Neurotrope Bioscience signs license agreement with Icahn School of Medicine at Mount Sinai. Jul 25, 2014 163
Puma Biotechnology & Pfizer amends Neratinib licensing agreement. Jul 23, 2014 192
Puma Biotechnology & Pfizer amends Neratinib licensing agreement. Jul 23, 2014 188
Allenex granted right to market and sell three new products under extended agreement with Conexio. Jun 16, 2014 336
ProBioGen, Merus sign GlymaxX license agreement. Apr 1, 2014 176
Ablynx signs second research collaboration and licensing agreement with Merck. Feb 5, 2014 134
Ablynx signs second research collaboration and licensing agreement with Merck. Feb 5, 2014 130
Janssen Biotech expands research collaboration and licensing agreement with Amunix. Jan 9, 2014 133
Janssen Biotech expands research collaboration and licensing agreement with Amunix. Jan 9, 2014 129
Switzerland : Lonza and BioWa Sign POTELLIGENTA CHOK1SV Cell Line Technology Licensing Agreement with MedImmune. Dec 13, 2013 368
Switzerland,United States : Lonza and BioWa Sign POTELLIGENT CHOK1SV Cell Line Technology Licensing Agreement with MedImmune. Dec 11, 2013 368
Advaxis Inc & Global BioPharma Inc signs exclusive licensing agreement for ADXS-HPV in Asia. Dec 10, 2013 264
Advaxis Inc & Global BioPharma Inc signs exclusive licensing agreement for ADXS-HPV in Asia. Dec 10, 2013 260
Ablynx And AbbVie enter into global license agreement for ALX-0061 for treating inflammatory diseases. Sep 24, 2013 231
Bioheart Inc to license adipose derived stem cells from Invitrx Therapeutics. Sep 24, 2013 137
Ablynx And AbbVie enter into global license agreement for ALX-0061 for treating inflammatory diseases. Sep 24, 2013 227
Bioheart Inc to license adipose derived stem cells from Invitrx Therapeutics. Sep 24, 2013 133
TGR BioSciences, Abcam ink licence deal for assay technology. Sep 23, 2013 131
Ablynx, AbbVie enter global licence agreement for ALX-0061. Sep 23, 2013 237
Germany : Bayer HealthCare signs license AGREEMENT with Compugen Ltd. Aug 8, 2013 260
Compugen, Bayer seal partnership, licence deal for antibody-based cancer immunotherapies. Aug 5, 2013 196
FIT Biotech signs global license and partnership agreement with KU Leuven. Aug 1, 2013 104
Ligand Pharmaceuticals Incorporated and Azure Biotech partnership to develop lasofoxifene targeting womena[euro](tm)s health. Jul 23, 2013 186
Ligand Pharmaceuticals Incorporated and Azure Biotech partnership to develop lasofoxifene targeting womena[euro](tm)s health. Jul 23, 2013 182
Asklepios and Genzyme enter into cross-license agreement for gene therapy technology. Jul 17, 2013 150
Asklepios and Genzyme enter into cross-license agreement for gene therapy technology. Jul 17, 2013 146
Alethia Biotherapeutics signs licensing and research agreement with International Biotechnology Centre Generium. Jun 3, 2013 178
Alethia Biotherapeutics signs licensing and research agreement with International Biotechnology Centre Generium. Jun 3, 2013 174
Australia,China,Germany,New Zealand : SYNCORE becomes largest shareholders of MEDIGENE, extending License Agreement for EndoTAG-1. May 28, 2013 265
Biotest Pharmaceuticals signs contract with ADMA Biologics. Jan 14, 2013 121
Biotest Pharmaceuticals signs contract with ADMA Biologics. Jan 14, 2013 117
Pharming receives USD10m milestone payment under license agreement with Santarus. Nov 26, 2012 160
Pharming receives USD10m milestone payment under license agreement with Santarus. Nov 26, 2012 156
Alnylam and Tekmira settle litigation and announce new licensing agreement. Nov 13, 2012 184
Alnylam and Tekmira settle litigation and announce new licensing agreement. Nov 13, 2012 180
Canada : Abattis signs LOI to purchase Bio-Pharma license and equipment from Vertical Design Systems Ltd. Oct 19, 2012 240
Japan : Astellas Enters License Agreement with Janssen to Develop and Commercialize ASP015K, an Astellas' Oral JAK Inhibitor for Immunologic Diseases. Oct 3, 2012 309
Janssen Biotech signs license agreement with Astellas Pharma. Oct 2, 2012 167
Janssen Biotech signs license agreement with Astellas Pharma. Oct 2, 2012 163
ShangPharma Corporation enters into antibody technology licensing agreement with Harbour Antibodies. Sep 14, 2012 132
ShangPharma Corporation enters into antibody technology licensing agreement with Harbour Antibodies. Sep 14, 2012 136
Marina Biotech Inc & Novartis signs worldwide non-exclusive licensing deal for nucleic acid chemistry. Aug 6, 2012 105
Marina Biotech Inc & Novartis signs worldwide non-exclusive licensing deal for nucleic acid chemistry. Aug 6, 2012 101
Marina Biotech Inc enters into worldwide non-exclusive licensing agreement for nucleic acid chemistry with Novartis. Aug 3, 2012 148
Marina Biotech Inc enters into worldwide non-exclusive licensing agreement for nucleic acid chemistry with Novartis. Aug 3, 2012 144
Sobi signs research collaboration and option agreement with Affibody AB. Jul 10, 2012 145
Sobi signs research collaboration and option agreement with Affibody AB. Jul 10, 2012 141
PDS Biotechnology Corporation signs licensing agreement with Merck KgaA. Jul 9, 2012 123
PDS Biotechnology Corporation signs licensing agreement with Merck KgaA. Jul 9, 2012 119
AstraZeneca and Rigel announce worldwide license agreement for R256. Jun 20, 2012 259
Islet Sciences Inc signs license agreement with Yale University for the worldwide diabetic community. May 8, 2012 198
Partnering with the NIH: now part of the "value proposition" for start-ups. Ferguson, Steven M. Report Apr 1, 2012 5209
Licensing, partnering, strategic alliances and university relationships. Blakeslee, Wesley D. Report Apr 1, 2012 2585
MediGene signs licensing agreement for Veregen with EIP Eczacibasi. Jan 23, 2012 145
XOMA signs licensing agreement for perindopril in US. Jan 18, 2012 147
Nuron Biotech signs vaccine licensing agreement with Japana[euro](tm)s MTPC. Jan 13, 2012 145
Alnylam, Arrowhead strike joint licensing contract. Jan 6, 2012 159
Phylogica, J&J's Janssen Biotech strike licence deal. Jan 3, 2012 157
Agenus, Russia's NewVac ink licence agreement for cancer vaccine. Dec 21, 2011 155
Janssen Biotech Inc signs development and worldwide license agreement for PCI-32765 for multiple B-Cell haematologic malignancies. Dec 9, 2011 242
MabCure signs exclusive licence deal with Biotech for prostate cancer diagnostic technology. Nov 23, 2011 181
MabCure Inc licenses prostate cancer diagnostic technology to Biotech Investment Corp. Nov 23, 2011 117
Daiichi Sankyo, ArQule strike licence agreement. Nov 10, 2011 161
Rosetta Genomics signs exclusive license agreement with Avatao Biotech to market miRview tests in China. Oct 14, 2011 191
GlycoMimetics, Pfizer sign licensing agreement for GMI-1070 for vaso-occlusive crisis caused by sickle cell disease. Oct 12, 2011 248
Ligand inks Fablyn licensing agreement with Chiva Pharmaceuticals. Oct 10, 2011 169
Pfizer and Puma Biotechnology sign licensing agreement for neratinib. Oct 6, 2011 157
Merck Serono inks licence agreement for multiple sclerosis drug PI-2301. Sep 19, 2011 133
Helicos BioSciences Corporation reports expanded patent license agreement to increase IP portfolio. Aug 31, 2011 115
Sequenom signs European Licensing Pact With LifeCodexx. Aug 30, 2011 539
Pharming extends license agreement with SOBI for the commercialisation of Ruconest. Aug 15, 2011 171
Pluristem Therapeutics Inc gets clearance for exclusive license agreement to develop and commercialise PLX Cells for PH. Aug 4, 2011 125
AbD Serotec, Merck sign licence agreement for HuCAL GOLD in vaccine research. Aug 1, 2011 166
AbD Serotec and Merck amend license agreement for use of HuCAL GOLD in vaccine research. Aug 1, 2011 166
Lilly forms BioCritica with private investment and signs Xigris license agreement. May 24, 2011 240
Allergan Inc and Molecular Partners sign exclusive licence deal for MP0112 for retinal diseases. May 5, 2011 171
Avjet Biotech Signs License Agreement with NC State to Commercialize Aviation Biofuel Technologies. Apr 21, 2011 489
Pieris and Daiichi Sankyo enter into collaboration and license agreement for Anticalin therapeutics. Apr 13, 2011 210
-Bioporto signs NGAL licence deal in USA. Mar 8, 2011 138
-Bioporto signs NGAL licence deal in USA. Mar 8, 2011 139
Biotechnology company Xoma Ltd (Berkeley CA) said it signed a development and licensing deal with Les Laboratoires Servier (Neuilly-sur-Seine FRA) potentially worth more than $500 million for an anti-inflammatory drug candidate. Jan 10, 2011 200
Nymox Pharmaceutical Corp executes European licensing deal with Recordati for NX-1207 for BPH. Dec 17, 2010 212
Life Technologies Corp licenses ErrASE from Novici Biotech LLC. Oct 12, 2010 136
Exelixis signs licensing agreement with Bristol-Myers Squibb for USD60m initial payment. Oct 11, 2010 297
Pieris enters into licence agreement with sanofi-aventis, Sanofi Pasteur. Sep 28, 2010 261
TriLink BioTechnologies signs licence agreement with Biofortuna. Sep 14, 2010 206
Itero teams up with Watson. Aug 30, 2010 291
Biogen Idec, Knopp Neurosciences ink licence agreement for KNS-760704. Aug 18, 2010 260
Swedish Probi announces licence agreement with Danone. Jul 30, 2010 204
Swedish Probi announces licence agreement with Danone. Jul 30, 2010 206
AbD Serotec signs exclusive license agreement for a key anti-PTH diagnostic antibody. Jul 26, 2010 235
MRC Technology (UK) signs exclusive licence deal with Genentech for small molecule drug candidates. Jul 12, 2010 179
MorphoSys and Xencor sign worldwide exclusive license and collaboration agreement for antibody programme. Jun 28, 2010 272
Danish Exiqon licenses LNA technology to US BD. Brief article Jun 21, 2010 175
Advaxis agrees amendment to licensing agreement with University of Pennsylvania. May 19, 2010 142
MediGene signs agreements in China and South Korea for licensing of Veregen. May 10, 2010 304
'Less is more' with the innovation of Avemar Fermented Wheat Germ Extract. May 1, 2010 536
Proximagen signs development, license, sub-license agreement for tonabersat. Apr 13, 2010 211
Vitrolife enters licensing deal on stem-cell cultivation media. Mar 31, 2010 206
Ipsen and Rhythm enter into license agreement for Ipsen's peptide therapeutics. Mar 12, 2010 204
Astra paying over $2 billion for Rigel arthritis drug. AstraZeneca Plc. Feb 22, 2010 394
AstraZeneca and Rigel Pharmaceuticals sign worldwide licence agreement for RA treatment. Feb 16, 2010 245
Cytokinetics, GSK agree to terminate collaboration and license agreement. Dec 10, 2009 261
Pfizer takes new direction with Protalix pact. Dec 7, 2009 584
Morphotek, Centocor enter antibody licensing deal. Nov 1, 2009 146
Valuation of complex license contracts. Villiger, Ralph; Bogdan, Boris Report Oct 1, 2009 3746
DEBIOPHARM/MERCURY SIGN LICENSE AGREEMENT FOR DEBIO 0930. Sep 1, 2009 626
Danish Affitech, US Peregrine ink antibody licence deal. Jul 23, 2009 191
Elan to sell its Alzheimer's immunotherapy program to J&J. Jul 20, 2009 386
Catalyst teams up with MedImmume. Jul 20, 2009 350
ITI achieves major milestone with first license. Brief article May 1, 2009 267
Genzyme Corp. Brief article Apr 6, 2009 233
Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test. Feb 1, 2009 761
Merck KGAA. Brief article Jan 19, 2009 154
Swedish biotech company BioGaia AB signs licence agreement with Mexican bottled water company Aqua Scandik. Jan 12, 2009 208
Pressure BioSciences and Battelle Sign Exclusive Protein Analysis Patent License Agreement. Dec 1, 2008 692
Swedish biotech company BioGaia AB signs licence agreement with Nestle. Aug 21, 2008 129
Nara Biosciences Inc. Inks License Agreement for MyoMouse Platform. Feb 6, 2008 311
ArQule Receives Payment for Initiation of ARQ 197 Trial in Japan. Feb 6, 2008 366
Rosetta selects PCR as platform for its microRNA-based diagnostics to be launched in 2008. Nov 1, 2007 418
Amicus and Shire enter Into $440 million ex-US licensing agreement to develop and commercialize lysosomal storage disorder technology. Oct 1, 2007 965
ONCOlog Medical QA AB signs licence agreement with Scandinavian Cancer Care AB. Brief article Jul 25, 2007 165
Clarient and Health Discovery initiate alliance with licensing agreement for new molecular diagnostic test for prostate cancer. Company overview Jul 1, 2007 809
ARQULE/KYOWA HAKKO KOGYO SIGN ARQ 197 ASIA LICENSE. Jun 1, 2007 654
Martek signs license and supply agreement. Brief article May 1, 2007 118
Swedish dietary supplements developer Probi AB expands market to Greece, the Czech Republic and Slovakia. Brief article Apr 12, 2007 196
Martek, mission Pharmacal sign supply agreement. Brief article Dec 1, 2006 99
Schering-Plough licenses worldwide rights to pradefovir, oral hepatitis B treatment in development with Valeant and Metabasis. Dec 1, 2006 524
Martek, WhiteWave sign agreement. Brief article Nov 1, 2006 127
Lux Biosciences gains exclusive worldwide license for ophthalmic polyarylate patent estate from Rutgers. Sep 1, 2006 858
Diamyd Medical AB signs licence agreement with Neurologix Inc. Brief article Aug 7, 2006 124
Ryogen licenses human aminopeptidase P gene patent to OriGene. Aug 1, 2006 360
Advanced BioNutrition Corp. Brief article Jun 1, 2006 115
BioActives Corporation. Brief article Jun 1, 2006 107
Ciba Specialty Chemicals forms JV with Biosignal. Brief article May 1, 2006 99
Chemel AB signs licence agreement with VivoMedical Inc. Brief Article Mar 2, 2006 137
Bioheart and Cleveland Clinic sign major patent licensing agreement. Jan 1, 2006 844
Bio-tech firm sells off rights to product. Dec 9, 2005 335
Stem Cell Sciences KK signs agreement with the University of Nice to commercialize stem cell therapy for degenerative disease. Brief Article Nov 30, 2005 238
Clarient and Health Discovery Corporation announce bioinformatics patent licensing agreement. Nov 1, 2005 908
Nanogen issued patent for technology enabling assay development to detect difficult nucleic acid sequences. Nov 1, 2005 359
Meristem obtains United States patent. Brief Article Nov 1, 2005 97
Genzyme signs licensing agreement with UCLA cancer center to develop CML markers. Oct 15, 2005 307
CRYO-CELL signs exclusive license to market new stem cell service. Company Profile Oct 1, 2005 1021
Stem Cell Therapy signs exclusive license agreement with Institute of Cell Therapy for supply of stem cells. Sep 30, 2005 257
InsectiGen enters licensing arrangement with Pioneer Hi-Bred. Aug 1, 2005 618
Agilent signals diagnostic plans for lab-on-a-chip. Brief Article Jul 15, 2005 161
Corautus announces collaboration and licensing agreement for treatment of diabetic neuropathy with VEGF-2. Jul 1, 2005 660
Lifebank Cryogenics, University of Alberta sign technology license agreement to pursue new clinical standard for stem cells. Brief Article May 23, 2005 223
CryoLife's cryopreserved orthopaedic tissues utilizing Clearant process implanted into human for first time. Brief Article May 13, 2005 140
Affymetrix licenses microfluidics technology from Caliper. Apr 1, 2005 546
BioTie Therapies Corporation signs licensing agreement with Biokine Therapeutics Ltd. Brief Article Jan 12, 2005 139
Cimab, Chinese firm sign biotech deal. Brief Article Jan 1, 2005 226
Genelabs Technologies receives $1.25 Million from Affymetrix for amendment to non-exclusive license for DNA amplification technology. Dec 1, 2004 368
Affymetrix agreement gives Veridex non-exclusive rights to GeneChip technology. Dec 1, 2004 289
Roche renews internal research license for patented gene targeting technology from Lexicon. Brief Article Dec 1, 2004 253
Biotage expands licence agreement with 454 Corporation. Brief Article Sep 17, 2004 162
Corgentech licenses peptide delivery system from Cyclacel. Sep 1, 2004 538
Bionomics licenses epilepsy test. Sep 1, 2004 696
Kereos and Dow sign licensing agreement for targeted imaging agents. Sep 1, 2004 558
AspenBio signs exclusive license with Washington University for reproductive patent estate. Jun 1, 2004 575
Peptimmune obtains exclusive license from Genzyme to develop and commercialize treatment for metabolic diseases including obesity. Jun 1, 2004 672
Juvaris Biotherapeutics announces licensing agreement for therapeutic vaccine platform. May 1, 2004 565
Peptimmune obtains exclusive license from Genzyme to develop and commercialize treatment for metabolic diseases including obesity. May 1, 2004 693
Geron grants XenoTrans license for nuclear transfer technology to produce transgenic pigs. Brief Article Apr 30, 2004 171
Biolin AB's MediTeam signs new licence agreement with Chinese partner Scienceway Biotechnologies Co. Brief Article Apr 1, 2004 124
fqubed concludes technology licensing agreement with Pharmacopeia. Apr 1, 2004 619
Affymetrix announces expanded genomic technologies licensing program. Apr 1, 2004 425
DOV Pharmaceutical reorganizes indiplon license. Mar 1, 2004 490

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters